Haywood Miller is an experienced leader in the business world, currently serving as the Interim CEO of Emergent BioSolutions, Inc. since June 2023. He has an impressive background with over 30 years in various roles including executive positions, private equity...

Haywood Miller is an experienced leader in the business world, currently serving as the Interim CEO of Emergent BioSolutions, Inc. since June 2023. He has an impressive background with over 30 years in various roles including executive positions, private equity investing, and legal expertise, especially in mergers and acquisitions. Before stepping into the top role at Emergent, Miller worked as a managing director at Berkeley Research Group, showcasing his skills in consulting and advisory services. Interestingly, he holds a law degree (J.D.) from the University of Maryland, which complements his business acumen. Under his watch as Interim CEO, Miller has focused on guiding the company through a transitional period, especially after the retirement of previous CEO Robert G. Kramer. Despite being in an interim position, Miller has already solidified his presence in the industry and is set to continue until a permanent CEO is appointed early next year.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Emergent Biosolutions CEOs

E

Haywood Miller

Ex-CEO of Emergent Biosolutions

Education

J.D. from the University of Maryland School of Law

Field of Expertise

Legal & Compliance - Law

Sector of Economy

Healthcare

Born

June 1, 1964 - 61 years ago

CEO of Emergent Biosolutions for

1 year 10 months (Apr 2022 - Feb 2024)

Previous Experience

Served in various executive roles at Emergent BioSolutions Inc.

Rivals

Competitors/colleagues of Haywood Miller

J

Joaquin Duato

CEO of Johnson & Johnson

2023 Compensation

Stock

$0.00

Salary

$1.58M

Bonus

$3.65M

Other

$241.99K

Total Holdings

$61.93M

Holdings

See how much did Haywood Miller make over time.

As of now, Haywood Miller does not own significant stock holdings in Emergent BioSolutions since he is serving as an Interim CEO. His appointment followed a sudden leadership change, but prior to his interim role, he had been advising the...

As of now, Haywood Miller does not own significant stock holdings in Emergent BioSolutions since he is serving as an Interim CEO. His appointment followed a sudden leadership change, but prior to his interim role, he had been advising the company. Miller's focus will likely define how he engages with stock ownership and company performance in the future. There have been no notable fluctuations in his holdings, as his primary objective is to stabilize the business as it seeks its next permanent leader. His role focuses more on steering the company's direction rather than personal investment accumulation. This situational awareness might change as the company navigates through its transition period and Miller potentially moves into a more long-term role.

Loading...

Insider Trading

See recent insider trades of Haywood Miller.

No insider trades found for this CEO.

Compensation History

See how much did Haywood Miller make over time.

In 2023, Haywood Miller's total compensation as Interim CEO was $1,500,000, all from his salary since he was not eligible for bonuses or stock awards during his interim tenure. His role is unique as he serves without the usual performance incentives granted to permanent CEOs, highlighting the temporary nature of his position. The previous year, his compensation totaled approximately $1,345,691, which included a reduced cash bonus reflecting the company's performance metrics being unmet at that time. These numbers reflect not just his current standing but also the transitional phase of Emergent that he is currently navigating. His compensation underscores the effort to retain experienced leadership during unstable times, as they align interests with the stockholders amid ongoing changes at the firm.

Year

2023

Total Compensation

$1.50M

Salary

$1.50M

Board Justification

The compensation philosophy of Emergent BioSolutions focuses on attracting and retaining top talent while aligning executive compensation with company performance and shareholder interests.

Bonus

$0.00

Board Justification

As Interim CEO, Mr. Miller was not eligible for a 2023 Target Cash Incentive.

Other

$0.00

Board Justification

Mr. Miller did not receive any other compensation in connection with his role as Interim CEO.

Restricted Stock

$0.00(0 N/A)

Board Justification

Mr. Miller was not eligible for equity incentive awards due to his status as Interim CEO.

Performance Metrics

The performance metrics for determining compensation were not applicable to Mr. Miller as he was not eligible for the annual cash incentive plan.

Other Emergent Biosolutions CEOs

Here are other CEOs of Emergent Biosolutions

Fuad El-Hibri

Founder and Ex-CEO of Emergent Biosolutions

May 2004 - April 2022

Joseph C. Papa

CEO of Emergent Biosolutions

February 2024 - Present